YAP downregulation resulted in p53 activation and cell cycle inhibition, and YAP depletion of ccRCC cells (786-O) also mitigated subcutaneous xenograft growth [32]. This evidence concerns the gene YAP1 and nonpapillary renal cell carcinoma.